Day: June 29, 2023

Posted on

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Futu Holdings Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FUTU

NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminder purchasers of the securities of Futu Holdings Limited (NASDAQ: FUTU) between April 27, 2020 and May 16, 2023, both dates inclusive (the “Class Period”), of the important August 11, 2023 lead plaintiff deadline, in the securities class action commenced by the Firm.

SO WHAT: If you purchased Futu securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Futu class action, go to https://rosenlegal.com/submit-form/?case_id=16261 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 11, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose, among other things, that: (1) Futu’s business was, quite simply, illegal as it related to operations in China as a result of its failure to obtain the proper licenses; (2) it did not fully disclose to investors that it was engaging in unlawful activity and instead falsely characterized the applicable Chinese laws as ambiguous; (3) the foregoing subjected the Company to a heightened risk of regulatory enforcement; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Futu class action, go to https://rosenlegal.com/submit-form/?case_id=16261 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8867116

Posted on

AROW INVESTOR NEWS: ROSEN, A LEADING LAW FIRM, Encourages Arrow Financial Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AROW

NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Arrow Financial Corporation (NASDAQ: AROW) between March 12, 2022 and May 12, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 22, 2023

SO WHAT: If you purchased Arrow securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Arrow class action, go to https://rosenlegal.com/submit-form/?case_id=17331 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 22, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose to investors that: (1) Arrow maintained defective disclosure controls and procedures and internal controls over financial reporting; (2) the foregoing increased the risk that the company could not timely file one or more of its periodic financial reports with the SEC as required by the NASDAQ’s listing requirements; (3) accordingly, Arrow was at an increased risk of being delisted from the NASDAQ; (4) following the disclosure of deficiencies in the Company’s disclosure controls and procedures and internal controls over financial reporting, Arrow downplayed the severity of these issued and the associated risks; and (5) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Arrow class action, go to https://rosenlegal.com/submit-form/?case_id=17331 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8867110

Posted on

Curia remporte le prix Frost & Sullivan 2023 du leadership de la valeur client

Curia est reconnue pour son offre d’une expérience client de premier ordre dans le secteur des organisations de recherche, de développement et de fabrication en sous-traitance (CRDMO) grâce à son approche innovante et à sa stratégie de croissance

ALBANY, N.Y., 29 juin 2023 (GLOBE NEWSWIRE) — Curia, une organisation de recherche, de développement et de fabrication en sous-traitance de premier plan, a annoncé aujourd’hui que Frost & Sullivan lui avait décerné le prix des Meilleures pratiques pour le leadership en matière de valeur client dans le secteur des CRDMO.

« Nous sommes très honorés de recevoir ce prix, qui récompense le travail acharné et le dévouement de tous nos employés pour offrir un service fiable et de qualité à nos clients », a déclaré Philip Macnabb, PDG de Curia. « Nous restons fidèles à notre noble objectif d’améliorer la vie des patients, une mission qui commence par notre engagement à créer de la valeur pour nos clients. »

Frost & Sullivan note dans son rapport qu’AMRI, en se rebaptisant Curia en 2021, a voulu mettre la science au cœur de son identité de marque, en insistant sur son engagement à aider les clients à progresser “de la curiosité à la guérison”. » Curia a évolué au fil du temps pour offrir une gamme complète de services allant de la découverte de médicaments et du développement à la fabrication de substances médicamenteuses et de produits pharmaceutiques pour les entreprises pharmaceutiques et biologiques. Ce prix récompense la manière dont Curia recherche des solutions innovantes en utilisant les technologies les plus récentes pour faire passer efficacement les produits de la découverte au développement et à l’échelle commerciale afin d’accélérer la mise sur le marché pour ses clients. Cet engagement continu à répondre aux besoins non formulés du marché et à fournir des solutions de bout en bout aux clients l’a positionnée en tant que leader du secteur.

« Curia a forgé sa réputation en offrant une expérience de relation et de service client de premier ordre. L’entreprise sonde ses clients pour évaluer leur satisfaction globale et s’assurer qu’elle respecte les normes les plus strictes », a déclaré Unmesh Lal, directeur du département Santé et sciences de la vie chez Frost & Sullivan.

Chaque année, Frost & Sullivan procède à une évaluation rigoureuse, mesurant l’impact sur l’économie et les clients, afin d’identifier les entreprises qui innovent constamment pour répondre aux besoins de leurs clients tout en relevant de nouveaux défis et en saisissant de nouvelles opportunités. Le gagnant est récompensé pour avoir offert une expérience client supérieure en termes de prix, de performance et de qualité.

À propos de Curia
Curia, anciennement AMRI, est une organisation de recherche, développement et fabrication en sous-traitance de premier plan qui fournit des produits et services allant de la R&D aux clients pharmaceutiques et biopharmaceutiques en passant par la fabrication commerciale. Basés sur 29 sites à travers les États-Unis, l’Europe et l’Asie, les près de 4 000 employés de Curia aident les clients de l’entreprise à passer de la curiosité à la guérison. Pour en savoir plus, rendez-vous sur CuriaGlobal.com.

À propos de Frost & Sullivan
Frost & Sullivan est la Growth Pipeline Company™. Nous propulsons nos clients vers un avenir façonné par la croissance. Notre Growth Pipeline as a Service™ fournit au PDG et à son équipe de croissance une plateforme continue et rigoureuse d’opportunités de croissance, garantissant un succès à long terme. Pour obtenir des résultats positifs, notre équipe s’appuie sur plus de 60 ans d’expérience, accompagnant des organisations de tous types et de toutes tailles sur 6 continents grâce à nos bonnes pratiques éprouvées. Pour alimenter l’avenir de votre pipeline de croissance, rendez-vous sur le site Web de Frost & Sullivan :http://www.frost.com.

Contact chez Curia :
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8866428

Posted on

Curia recebe Prêmio de Liderança de Valor do Cliente 2023 Frost & Sullivan

A Curia é conhecida por fornecer uma experiência de cliente de primeira classe na indústria de CRDMO através da sua inovadora abordagem e estratégia de crescimento

ALBANY, N.Y., June 29, 2023 (GLOBE NEWSWIRE) — A Curia, uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje que recebeu o Prêmio de Melhor Prática de Liderança de Valor do Cliente na indústria de CRDMO da Frost & Sullivan.

“Estamos muito honrados em receber este prêmio que destaca o trabalho árduo e a dedicação de todos os nossos funcionários em oferecer qualidade e confiabilidade ao servir nossos clientes”, disse Philip Macnabb, CEO da Curia. “Continuamos firmes no nosso nobre propósito de melhorar a vida dos pacientes, uma missão que tem início com o nosso compromisso de criar valor para nossos clientes.”

No seu relatório a Frost & Sullivan observou que a mudança da marca da empresa de AMRI para Curia em 2021 colocou o foco da ciência no centro da identidade da sua marca, destacando uma promessa de ajudar os clientes a avançar “da curiosidade para a cura”. A Curia evoluiu ao longo do tempo para oferecer uma gama abrangente de serviços, desde a descoberta de medicamentos até o desenvolvimento e fabricação de medicamentos e produtos farmacêuticos para empresas farmacêuticas e biológicas. O prêmio é um reconhecimento de como a Curia procura soluções inovativas por meio de tecnologias mais avançadas para avançar eficientemente os produtos da fase da descoberta para a fase do desenvolvimento em escala comercial, e acelerar a velocidade do lançamento no mercado para seus clientes. Esse compromisso contínuo de atender às necessidades tácitas do mercado e fornecer soluções completas para os clientes a posicionou como líder do setor.

“A Curia desenvolveu sua reputação com a oferta de produtos e experiência de serviços ao cliente de primeira classe. A empresa pesquisa os clientes para avaliar sua satisfação geral e garantir os mais altos padrões de qualidade”, disse Unmesh Lal, diretor de Saúde e Ciências da Vida da Frost & Sullivan.

Todos os anos, a Frost & Sullivan faz uma avaliação rigorosa, medindo o impacto nos negócios e nos clientes, para identificar empresas que estejam inovando com consistência para atender às necessidades dos seus clientes e navegar por novos desafios e oportunidades. O vencedor foi premiado por fornecer uma experiência superior ao cliente em termos de preços, desempenho e qualidade em geral.

Sobre a Curia
A Curia, ex-AMRI, é uma organização líder em contratos de pesquisa, desenvolvimento e fabricação que fornece produtos e serviços de P&D por meio da fabricação comercial para clientes farmacêuticos e biofarmacêuticos. Os quase 4.000 funcionários da Curia em 29 locais nos EUA, Europa e Ásia ajudam seus clientes a avançar da curiosidade para a cura. Saiba mais em CuriaGlobal.com.

Sobre a Frost & Sullivan
A Frost & Sullivan é a Growth Pipeline Company™. Capacitamos nossos clientes para um futuro moldado pelo crescimento. Nosso Growth Pipeline as a Service™ fornece aos CEOs e equipes de crescimento dos CEOs uma plataforma contínua e rigorosa de oportunidades de crescimento, garantindo o sucesso a longo prazo. Para alcançar resultados positivos, nossa equipe utiliza nossos mais de 60 anos de experiência para treinar organizações de todos os tipos e tamanhos em 6 continentes com nossas melhores práticas comprovadas. Para impulsionar o seu Growth Pipeline futuro, visite a Frost & Sullivan em http://www.frost.com.

Contato da Curia:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8866428

Posted on

Curia wins 2023 Frost & Sullivan Customer Value Leadership Award

Curia recognized for providing a best-in-class customer experience in the CRDMO industry through its innovative approach and growth strategy

ALBANY, N.Y., June 29, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a Best Practices Customer Value Leadership Award in the CRDMO industry by Frost & Sullivan.

“We are very honored to be recognized with this award, which underlines the hard work and dedication of all of our employees to delivering quality and reliability when serving our customers,” said Philip Macnabb, CEO, Curia. “We remain steadfast in our noble purpose of improving patients’ lives, a mission that begins with our commitment to creating value for our customers.”

Frost & Sullivan noted in its report that the company’s rebrand from AMRI to Curia in 2021 put a focus on science at the center of its brand identity, highlighting a pledge to help customers advance “from curiosity to cure.” Curia has evolved over time to offer a comprehensive range of services from drug discovery through development to manufacture of both drug substance and drug product for pharmaceutical and biologics companies. The award recognizes how Curia seeks out innovative solutions by using the latest technologies to efficiently move products from discovery to development to commercial scale to accelerate speed to market for its customers. This continuous commitment to serve unspoken market needs and deliver end-to-end solutions for customers has positioned it as an industry leader.

“Curia has built its reputation by offering a best-in-class customer ownership and service experience. The company surveys clients to gauge their overall satisfaction and ensure that it is upholding the highest standards,” said Unmesh Lal, director, Healthcare & Life Sciences, Frost & Sullivan.

Each year, Frost & Sullivan employs a rigorous evaluation, measuring business and customer impact, to identify companies that consistently innovate to meet their customers’ needs while navigating new challenges and opportunities. The winner is recognized for providing a superior customer experience for overall price, performance and quality.

About Curia
Curia, formerly AMRI, is a leading contract research, development, and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s nearly 4,000 employees at 29 locations across the U.S., Europe, and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.

About Frost & Sullivan
Frost & Sullivan is the Growth Pipeline Company™. We power our clients to a future shaped by growth. Our Growth Pipeline as a Service™ provides the CEO and the CEO’s growth team with a continuous and rigorous platform of growth opportunities, ensuring long-term success. To achieve positive outcomes, our team leverages over 60 years of experience, coaching organizations of all types and sizes across 6 continents with our proven best practices. To power your Growth Pipeline future, visit Frost & Sullivan at http://www.frost.com.

Curia Contact Information:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8865503

Posted on

WilsonHCG nommée Leader et Entreprise hors pair dans l’évaluation mondiale PEAK Matrix® 2023 des services RPO d’Everest Group

TAMPA, Floride, 29 juin 2023 (GLOBE NEWSWIRE) — WilsonHCG a été nommée Leader et Entreprise hors pair (Star Performer) une fois encore dans l’évaluation mondiale PEAK Matrix® 2023 des services d’externalisation des processus de recrutement (RPO) d’Everest Group.

La PEAK Matrix® analyse la dynamique changeante du paysage de la RPO, fournissant une évaluation comparative objective et basée sur les données de 45 fournisseurs de RPO en fonction de leur capacité globale sur différents marchés mondiaux.

« Nous sommes honorés d’avoir été nommés Leader et Entreprise hors pair une fois encore. Nos équipes s’efforcent chaque jour d’aider nos clients à améliorer leurs activités. Leur dévouement à atteindre l’excellence est crucial dans le paysage des talents en évolution rapide d’aujourd’hui », a déclaré John Wilson, PDG de WilsonHCG. « Nous sommes également fiers de notre position de Concurrent de premier plan dans l’APAC, car c’est une région dans laquelle nous avons poursuivi notre expansion au cours des 12 derniers mois. »

S’exprimant à propos du statut mondial de WilsonHCG en tant que Leader et Entreprise hors pair, Arkadev Basak, partenaire chez Everest Group, a commenté : « Outre son expertise profonde en matière d’approvisionnement de talents hautement qualifiés de niche, WilsonHCG se démarque en raison de son empreinte mondiale et de ses offres analytiques. Son acquisition de Claro et Tracking Talent a renforcé ses offres de services et a aidé à positionner WilsonHCG comme un Leader et une Entreprise hors pair dans l’évaluation mondiale PEAK Matrix® 2023 des services d’externalisation des processus de recrutement (RPO) d’Everest Group. »

Les solides antécédents de WilsonHCG en matière de recrutement de cols blancs hautement qualifiés et son engagement redoublé dans le secteur des soins de santé et des sciences de la vie ont été salués par Everest Group, ainsi que sa capacité de livraison significative en Amérique du Nord et sa forte présence dans la région EMOA.

Autres faits saillants retenus dans l’évaluation :

  • Comment le réseau de centres de livraison mondiaux de WilsonHCG soutient de multiples industries d’acheteurs.
  • Le vaste réseau de partenariats de la société avec des fournisseurs de technologie.
  • Son acquisition de Claro en vue de fournir une offre de premier plan pour la veille du marché des talents.

WilsonHCG a également été nommée Leader et Entreprise hors pair en Amérique du Nord, Concurrent de premier plan et Entreprise hors pair dans la région EMOA, ainsi que Concurrent de premier plan dans la région APAC.

M. Basak a ajouté : « WilsonHCG es un acteur clé en Amérique du Nord grâce à ses fortes capacités de livraison et à sa faculté de recruter des cols blancs de niche en particulier dans les secteurs des hautes technologies, des soins de santé et des sciences de la vie. Sa série d’investissements organiques et inorganiques visant à accroître sa pénétration du marché et à améliorer ses capacités technologiques et ses offres de conseil a contribué a son positionnement en tant que Leader et Entreprise hors pair dans l’évaluation PEAK Matrix® 2023 Amérique du Nord des services d’externalisation des processus de recrutement (RPO) d’Everest Group. »

Pour en savoir plus sur l’évaluation PEAK Matrix®, veuillez consulter le site Internet d’Everest Group.

À propos de WilsonHCG

WilsonHCG est un leader mondial primé dans les solutions totales de talents. Opérant en tant que partenaire stratégique, la société aide certaines de marques les plus admirées au monde à développer des fonctions de talents complètes. Grâce à une présence mondiale couvrant plus de 65 pays et six continents, WilsonHCG fournit une suite complète de services de talents configurables, notamment l’externalisation des processus de recrutement (RPO), la recherche de cadres, ainsi que des solutions de gestion de talents et de conseil en technologie.

TALENT. ™ Plus qu’une solution, c’est notre identité.

www.wilsonhcg.com

Contact auprès des médias
Kirsty Hewitt
+44 7889901517
kirsty.hewitt@wilsonhcg.com

Une photo accompagnant ce communiqué de presse est disponible à l’adresse https://www.globenewswire.com/NewsRoom/AttachmentNg/4e63ef5e-761d-4037-b8b5-adce40d52acd

GlobeNewswire Distribution ID 8866954